OA12.03 Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLCS. Li, Benjamin G. Neel, Jayu Jen et al.|Journal of Thoracic Oncology|2021Cited by 0